48 related articles for article (PubMed ID: 18854267)
1. Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus.
van Dekken H; Hop WC; Tilanus HW; Haringsma J; van der Valk H; Wink JC; Vissers KJ
Am J Clin Pathol; 2008 Nov; 130(5):745-53. PubMed ID: 18854267
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast Activation Protein-α (FAP) Identifies Stromal Invasion in Colorectal Neoplasia.
Tarín-Nieto A; Solano-Iturri JD; Arrieta-Aguirre I; Valdivia A; Etxezarraga MC; Loizate A; López JI; Larrinaga G
Am J Surg Pathol; 2023 Sep; 47(9):1027-1033. PubMed ID: 37366169
[TBL] [Abstract][Full Text] [Related]
3. Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation.
Stetka J; Vyhlidalova P; Lanikova L; Koralkova P; Gursky J; Hlusi A; Flodr P; Hubackova S; Bartek J; Hodny Z; Divoky V
Oncogene; 2019 Jul; 38(28):5627-5642. PubMed ID: 30967632
[TBL] [Abstract][Full Text] [Related]
4. Predicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program.
Zhang H; Li H; Ma Q; Yang FY; Diao TY
World J Gastroenterol; 2016 Oct; 22(39):8770-8778. PubMed ID: 27818592
[TBL] [Abstract][Full Text] [Related]
5. A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus.
Critchley-Thorne RJ; Duits LC; Prichard JW; Davison JM; Jobe BA; Campbell BB; Zhang Y; Repa KA; Reese LM; Li J; Diehl DL; Jhala NC; Ginsberg G; DeMarshall M; Foxwell T; Zaidi AH; Lansing Taylor D; Rustgi AK; Bergman JJ; Falk GW
Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):958-68. PubMed ID: 27197290
[TBL] [Abstract][Full Text] [Related]
6. TissueCypher(™): A systems biology approach to anatomic pathology.
Prichard JW; Davison JM; Campbell BB; Repa KA; Reese LM; Nguyen XM; Li J; Foxwell T; Taylor DL; Critchley-Thorne RJ
J Pathol Inform; 2015; 6():48. PubMed ID: 26430536
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of Barrett's esophagus.
Fouad YM; Mostafa I; Yehia R; El-Khayat H
World J Gastrointest Pathophysiol; 2014 Nov; 5(4):450-6. PubMed ID: 25400988
[TBL] [Abstract][Full Text] [Related]
8. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma.
Zaidi AH; Gopalakrishnan V; Kasi PM; Zeng X; Malhotra U; Balasubramanian J; Visweswaran S; Sun M; Flint MS; Davison JM; Hood BL; Conrads TP; Bergman JJ; Bigbee WL; Jobe BA
Cancer; 2014 Dec; 120(24):3902-13. PubMed ID: 25100294
[TBL] [Abstract][Full Text] [Related]
10. Barrett's oesophagus: epidemiology, cancer risk and implications for management.
de Jonge PJ; van Blankenstein M; Grady WM; Kuipers EJ
Gut; 2014 Jan; 63(1):191-202. PubMed ID: 24092861
[TBL] [Abstract][Full Text] [Related]
11. Predictive biomarkers for Barrett's esophagus: so near and yet so far.
Timmer MR; Sun G; Gorospe EC; Leggett CL; Lutzke L; Krishnadath KK; Wang KK
Dis Esophagus; 2013 Aug; 26(6):574-81. PubMed ID: 23316980
[TBL] [Abstract][Full Text] [Related]
12. Barrett's esophagus: A review of diagnostic criteria, clinical surveillance practices and new developments.
Booth CL; Thompson KS
J Gastrointest Oncol; 2012 Sep; 3(3):232-42. PubMed ID: 22943014
[TBL] [Abstract][Full Text] [Related]
13. Barrett's Esophagus: Emerging Knowledge and Management Strategies.
Bhardwaj A; McGarrity TJ; Stairs DB; Mani H
Patholog Res Int; 2012; 2012():814146. PubMed ID: 22701199
[TBL] [Abstract][Full Text] [Related]
14. Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.
Garman KS; Orlando RC; Chen X
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1231-43. PubMed ID: 22421618
[TBL] [Abstract][Full Text] [Related]
15. The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells.
Sehdev V; Peng D; Soutto M; Washington MK; Revetta F; Ecsedy J; Zaika A; Rau TT; Schneider-Stock R; Belkhiri A; El-Rifai W
Mol Cancer Ther; 2012 Mar; 11(3):763-74. PubMed ID: 22302096
[TBL] [Abstract][Full Text] [Related]
16. MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib.
Lennerz JK; Kwak EL; Ackerman A; Michael M; Fox SB; Bergethon K; Lauwers GY; Christensen JG; Wilner KD; Haber DA; Salgia R; Bang YJ; Clark JW; Solomon BJ; Iafrate AJ
J Clin Oncol; 2011 Dec; 29(36):4803-10. PubMed ID: 22042947
[TBL] [Abstract][Full Text] [Related]
17. [Intraepithelial neoplasia of Barrett's esophagus: prognosis of potential malignancy].
Werner M; Lassmann S
Pathologe; 2011 Nov; 32 Suppl 2():197-201. PubMed ID: 22033682
[TBL] [Abstract][Full Text] [Related]
18. Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma.
Vega KJ; May R; Sureban SM; Lightfoot SA; Qu D; Reed A; Weygant N; Ramanujam R; Souza R; Madhoun M; Whorton J; Anant S; Meltzer SJ; Houchen CW
J Gastroenterol Hepatol; 2012 Apr; 27(4):773-80. PubMed ID: 21916995
[TBL] [Abstract][Full Text] [Related]
19. American Gastroenterological Association technical review on the management of Barrett's esophagus.
Spechler SJ; Sharma P; Souza RF; Inadomi JM; Shaheen NJ;
Gastroenterology; 2011 Mar; 140(3):e18-52; quiz e13. PubMed ID: 21376939
[No Abstract] [Full Text] [Related]
20. Biomarkers in Barrett's Esophagus.
Souza RF
Tech Gastrointest Endosc; 2010 Apr; 12(2):116-1212. PubMed ID: 20657812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
